Get Live Data

The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Shire Share Price
  4. Shire Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksShire Share News (SHP)

Shire Information
  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 24th Jul 2018 16:06

Wednesday 25 July 
GlaxoSmithKlineHalf Year Results (at 1200 BST)
Vodafone GroupTrading Statement 
Joules GroupFull Year Results 
Wizz AirQ1 Results 
Staffline GroupHalf Year Results 
QuartixHalf Year Results 
IndiviorHalf Year Results 
Burford CapitalHalf Year Results 
Fulham ShoreHalf Year Results 
IDOXHalf Year Results 
IP GroupHalf Year Results 
QinetiQQ1 Results 
Capital & Counties PropertiesHalf Year Results 
InformaHalf Year Results 
Croda InternationalHalf Year Results 
TymanHalf Year Results 
Rathbone BrothersHalf Year Results 
VictrexHalf Year Results 
3i GroupTrading Statement 
AntofagastaQ2 Production
Brewin DolphinTrading Statement 
FresnilloQ2 Production
International Personal FinanceHalf Year Results 
ITVHalf Year Results 
Marston'sTrading Statement 
Metro BankHalf Year Results 
Tullow OilHalf Year Results 
Primary Health PropertiesHalf Year Results 
Thursday 26 July 
Royal Dutch ShellHalf Year Results
SchrodersHalf Year Results
SkyFull Year Results
Intu PropertiesHalf Year Results
Howden Joinery Group Half Year Results
EvrazTrading Statement 
Discoverie Group Trading Statement 
Intermediate Capital GroupTrading Statement 
Law Debenture CorpHalf Year Results
SEGRO Half Year Results
Virgin MoneyHalf Year Results
Sage Group Trading Statement 
Compass GroupTrading Statement 
PayPointTrading Statement 
Tarsus Group Half Year Results
Anglo American Half Year Results
AstraZenecaHalf Year Results
BodycoteHalf Year Results
British American TobaccoHalf Year Results
Countrywide Half Year Results
Daily Mail and General TrustTrading Statement 
DiageoFull Year Results
Impellam GroupHalf Year Results
Inchcape Half Year Results
Jardine Lloyd Thompson GroupHalf Year Results
KAZ Minerals Q2 Production
Sophos Q1 Results
Lancashire HoldingsHalf Year Results
National Express GroupHalf Year Results
RELX Half Year Results
RenishawFull Year Results
Smith & Nephew Half Year Results
Tate & LyleTrading Statement 
Vesuvius Half Year Results
Morgan Advanced Materials Half Year Results
Countryside PropertiesQ3 Results
Franchise BrandsHalf Year Results
CMC MarketsTrading Statement 
Polymetal InternationalQ2 Production
AVEVA GroupTrading Statement 
De La RueTrading Statement 
Friday 27 July 
DX (Group) Trading Statement 
Reckitt BenckiserHalf Year Results
Jupiter Fund Management Half Year Results
BT GroupQ1 Results
Equiniti Group Half Year Results
Rightmove Half Year Results
CYBG Trading Statement 
Hutchison China MeditechHalf Year Results
PearsonHalf Year Results
Monday 30 July 
CranswickTrading Statement 
DialightHalf Year Results
Foxtons GroupHalf Year Results
Keller GroupHalf Year Results
SeniorHalf Year Results
ReachHalf Year Results
XP PowerHalf Year Results
CYBGTrading Statement 
ForterraHalf Year Results
River & MercantileTrading Statement 
JKX Oil & GasHalf Year Results
Tuesday 31 July 
ElementisHalf Year Results
BPHalf Year Results
ShireHalf Year Results (at 1200 BST)
Standard CharteredHalf Year Results (at 0515 BST)
Rentokil InitialHalf Year Results
Just EatHalf Year Results
CentricaHalf Year Results
LSL PropertyHalf Year Results
Sabre Insurance GroupHalf Year Results
River & MercantileTrading Statement 
GreggsHalf Year Results
Games WorkshopHalf Year Results
Provident FinancialHalf Year Results
VolexTrading Statement 
GlencoreQ2 Production
Thomas Cook GroupTrading Statement 
IMIHalf Year Results
4imprint GroupHalf Year Results
Weir GroupHalf Year Results
FresnilloQ2 Production
Gocompare.comHalf Year Results
Travis PerkinsHalf Year Results
Taylor WimpeyHalf Year Results
  

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.